EUVIMEDEUVIMED entdecken
Crossref

Evaluating Outcomes of Live‐Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis

Grace Eleanor Sessler Bruess iD, Kelly K Barry iD, Gerilyn M Olsen iD, Cristina M Foschi, Elizabeth Cook, Melodee Liegl, Amy Y Pan, Leah Lalor

Pediatric Dermatology · 2026

DOI: 10.1111/pde.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Grace Eleanor Sessler Bruess und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical College of Wisconsin, Milwaukee, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Vaccines, Attenuated. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Wisconsin Medical Society Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dupilumab is an IL‐4R α and IL‐13 inhibitor FDA‐approved for the treatment of atopic dermatitis (AD) in patients 6 months and older. Guidelines recommend against live‐attenuated vaccines due to limited safety data. We conducted a retrospective chart review of 233 patients aged 6 months to 10 years receiving dupilumab for AD at Children's Wisconsin, which showed that 19 received live vaccines during the study period. Four patients reported adverse events, including one requiring hospitalization. This study aims to evaluate the effects of live vaccines in children on dupilumab therapy and to assess associated adverse events, including in patients receiving their primary series of vaccines, a setting not previously described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedVaccines, AttenuatedHumansRetrospective StudiesChildMaleFemaleChild, PreschoolInfantTreatment Outcome

Stichwörter der Autor:innen

MMRatopic dermatitisdupilumablive‐attenuated vaccines

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedVaccines, Attenuated

Autor:innen und Institutionen

  • Department of Dermatology, Medical College of Wisconsin, Milwaukee, USA.
  • Division of Bioinformatics and Quantitative Child Health, Medical College of Wisconsin, Milwaukee, USA.

ORCID-Profile: Grace Eleanor Sessler Bruess, Kelly K Barry, Gerilyn M Olsen

Förderung

  • Wisconsin Medical Society Foundation

Zitieren

APA

Bruess, G. E. S., Barry, K. K., Olsen, G. M., Foschi, C. M., Cook, E., Liegl, M., Pan, A. Y., & Lalor, L. (2026). Evaluating Outcomes of Live‐Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis. Pediatric Dermatology. https://doi.org/10.1111/pde.70033

Vancouver

Bruess GES, Barry KK, Olsen GM, Foschi CM, Cook E, Liegl M, et al. Evaluating Outcomes of Live‐Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis. Pediatric Dermatology. 2026. doi:10.1111/pde.70033

BibTeX
@article{Bruess2026,
  author = {Bruess, Grace Eleanor Sessler and Barry, Kelly K and Olsen, Gerilyn M and Foschi, Cristina M and Cook, Elizabeth and Liegl, Melodee and Pan, Amy Y and Lalor, Leah},
  title = {Evaluating Outcomes of Live‐Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70033}
}
Kostenlos starten →